BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24961900)

  • 1. Quantitative immunohistochemical assessment of IgA, IgM, IgG and antigen-specific immunoglobulin secreting plasma cells in pig small intestinal lamina propria.
    Bianco C; Felice V; Panarese S; Marrocco R; Ostanello F; Brunetti B; Muscatello LV; Leotti G; Vila T; Joisel F; Sarli G
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):281-7. PubMed ID: 24961900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high and low levels of maternally derived antibodies on porcine circovirus type 2 (PCV2) infection dynamics and production parameters in PCV2 vaccinated pigs under field conditions.
    Feng H; Segalés J; Fraile L; López-Soria S; Sibila M
    Vaccine; 2016 Jun; 34(27):3044-3050. PubMed ID: 27155497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
    Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
    Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
    Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2.
    Opriessnig T; Patterson AR; Elsener J; Meng XJ; Halbur PG
    Clin Vaccine Immunol; 2008 Mar; 15(3):397-401. PubMed ID: 18094109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
    Jeong J; Park C; Choi K; Chae C
    Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porcine circovirus type 2 (PCV2) infection decreases the efficacy of an attenuated classical swine fever virus (CSFV) vaccine.
    Huang YL; Pang VF; Lin CM; Tsai YC; Chia MY; Deng MC; Chang CY; Jeng CR
    Vet Res; 2011 Dec; 42(1):115. PubMed ID: 22129109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication.
    Meerts P; Van Gucht S; Cox E; Vandebosch A; Nauwynck HJ
    Viral Immunol; 2005; 18(2):333-41. PubMed ID: 16035945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sow and piglet porcine circovirus type 2 (PCV2) vaccination on piglet mortality, viraemia, antibody titre and production parameters.
    Fraile L; Sibila M; Nofrarías M; López-Jimenez R; Huerta E; Llorens A; López-Soria S; Pérez D; Segalés J
    Vet Microbiol; 2012 Dec; 161(1-2):229-34. PubMed ID: 22858231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vaccination of boars against porcine circovirus type 2 on ejaculate characteristics, serum antibody titers, viremia, and semen virus shedding.
    Alberti KA; Estienne MJ; Meng XJ
    J Anim Sci; 2011 May; 89(5):1581-7. PubMed ID: 21169515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine reproductive and respiratory syndrome virus (PRRSV) influences infection dynamics of porcine circovirus type 2 (PCV2) subtypes PCV2a and PCV2b by prolonging PCV2 viremia and shedding.
    Sinha A; Shen HG; Schalk S; Beach NM; Huang YW; Meng XJ; Halbur PG; Opriessnig T
    Vet Microbiol; 2011 Sep; 152(3-4):235-46. PubMed ID: 21641124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the natural response of immunoglobulin secreting cells in the pig as a function of organ, age and housing.
    Bianchi AT; Scholten JW; Moonen Leusen BH; Boersma WJ
    Dev Comp Immunol; 1999 Sep; 23(6):511-20. PubMed ID: 10512461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of dams increases antibody titer and improves growth parameters in finisher pigs subclinically infected with porcine circovirus type 2.
    Kurmann J; Sydler T; Brugnera E; Buergi E; Haessig M; Suter M; Sidler X
    Clin Vaccine Immunol; 2011 Oct; 18(10):1644-9. PubMed ID: 21852549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged detection of PCV2 and anti-PCV2 antibody in oral fluids following experimental inoculation.
    Prickett JR; Johnson J; Murtaugh MP; Puvanendiran S; Wang C; Zimmerman JJ; Opriessnig T
    Transbound Emerg Dis; 2011 Apr; 58(2):121-7. PubMed ID: 21223532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent porcine circovirus type 2-infected domestic pigs: A potential infection model for the effective development of vaccines against latent or chronic virus induced diseases.
    Sydler T; Brägger S; Handke M; Hartnack S; Lewis FI; Sidler X; Brugnera E
    Vaccine; 2016 Feb; 34(8):1047-53. PubMed ID: 26795369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy.
    Sinha A; Shen HG; Schalk S; Beach NM; Huang YW; Halbur PG; Meng XJ; Opriessnig T
    Clin Vaccine Immunol; 2010 Dec; 17(12):1940-5. PubMed ID: 20926694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis of TNF-alpha response in pigs challenged with porcine circovirus 2b.
    Kreikemeier CA; Engle TB; Lucot KL; Kachman SD; Burkey TE; Ciobanu DC
    Anim Genet; 2015 Apr; 46(2):205-8. PubMed ID: 25643812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of neutralizing and non-neutralizing antibody responses against Porcine circovirus 2 in vaccinated and non-vaccinated farmed pigs.
    Solis Worsfold C; Dardari R; Law S; Eschbaumer M; Nourozieh N; Marshall F; Czub M
    J Gen Virol; 2015 Sep; 96(9):2743-2748. PubMed ID: 26033118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus.
    Opriessnig T; Fenaux M; Yu S; Evans RB; Cavanaugh D; Gallup JM; Pallares FJ; Thacker EL; Lager KM; Meng XJ; Halbur PG
    Vet Microbiol; 2004 Mar; 98(3-4):209-20. PubMed ID: 15036529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.